Behandlung des fortgeschrittenen nichtkleinzelligen Bronchialkarzinoms —eine Literaturrecherche der letzten 5 Jahre
作者： A. Prokop , J.M. Miller , H. Pichlmaier
DOI: 10.1007/BF00205125
关键词:
摘要: In the course of a metaanalysis concerning adjuvant therapy and inoperable non-small-cell carcinoma lung, undertaken from 1.1. 1985 to 1.5. 1990, 376 publications were evaluated on point system based decision tree. Out maximum 71 obtainable points only 5.4% 7.3% palliative obtained more than 45 points. Regarding cases X-ray with median survival 11 months satisfactory life quality demonstrated best results. Significant increases in are also possible chemotherapy (7.4 months) standard-dose pair combinations which, however, associated negative side effects treated patients. Immune radio-chemotherapy cannot be recommended account treatment toxicity without gain quality. Adjuvant shows no life-prolonging effect. Consequently surgical remains first choice therapy.
springer.com
sci-hub.se 参考文章(24)
I Verturo, F Ambesi Impiombato, G B Ciottoli, M R Del Vecchio, C Gallo-Curcio, F Tropea, A Antilli, R Tonachella, M Rinaldi, M De Gregorio, Chemotherapy/radiation therapy plus/minus lonidamine in the treatment of non-small cell lung cancer (limited disease): preliminary results. Seminars in Oncology. ,vol. 15, pp. 26- 31 ,(1988)
E. CARMACK HOLMES, LUCIUS D. HILL, MITCHELL GAIL, A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group. Annals of Surgery. ,vol. 202, pp. 335- 341 ,(1985) , 10.1097/00000658-198509000-00010
R Grilli, M Leoni, S Scoccia, C Vergari, U Borghini, G Luporini, E Soresi, M Botturi, M Clerici, R Zucali, A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Seminars in Oncology. ,vol. 15, pp. 20- 25 ,(1988)
H M Golomb, R R Blough, P C Hoffman, C Skosey, M K Ferguson, A G Little, D B Skinner, T R DeMeester, Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. Surgery. ,vol. 100, pp. 621- 628 ,(1986)
J. Schirren, T. Muley, P. Schneider, L. Latzke, H. Bülzebruck, I. Vogt-Moykopf, Chirurgische Therapie des Bronchialkarzinoms Thoraxtumoren. pp. 232- 269 ,(1998) , 10.1007/978-3-642-72041-3_12
J C Ruckdeschel, D M Finkelstein, B A Mason, R H Creech, Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens. Journal of Clinical Oncology. ,vol. 3, pp. 72- 79 ,(1985) , 10.1200/JCO.1985.3.1.72
J Klastersky, J P Sculier, G Bureau, P Libert, P Ravez, G Vandermoten, J Thiriaux, J Lecomte, R Cordier, G Dabouis, Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium. Journal of Clinical Oncology. ,vol. 7, pp. 1087- 1092 ,(1989) , 10.1200/JCO.1989.7.8.1087
E Rapp, J L Pater, A Willan, Y Cormier, N Murray, W K Evans, D I Hodson, D A Clark, R Feld, A M Arnold, Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. Journal of Clinical Oncology. ,vol. 6, pp. 633- 641 ,(1988) , 10.1200/JCO.1988.6.4.633
Mary Evans, A. V. Pollock, A score system for evaluating random control clinical trials of prophylaxis of abdominal surgical wound infection British Journal of Surgery. ,vol. 72, pp. 256- 260 ,(2005) , 10.1002/BJS.1800720403
M.J. Barnett, W. Gregory, J.P.S. Thompson, P.F.M. Wrigley, V.J. Harvey, M.L. Slevin, S.P. Cheek, A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma European Journal of Cancer and Clinical Oncology. ,vol. 23, pp. 1615- 1619 ,(1987) , 10.1016/0277-5379(87)90439-1